Trial Profile
A retrospective, observational cohort study assessing the impact of switching from a higher tariff DPP-4i to alogliptin on glycaemic control in a primary care setting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Oct 2018
Price :
$35
*
At a glance
- Drugs Alogliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 22 Oct 2018 New trial record
- 05 Oct 2018 Results presented at the 54th Annual Meeting of the European Association for the Study of Diabetes